Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized, open, parallel group study for the evaluation of an oral dose of 100 mg thalidomide and subsequent dose escalation of 400 mg thalidomide in combination with riluzole in patients with amyotrophic lateral sclerosis (ALS).

X
Trial Profile

Randomized, open, parallel group study for the evaluation of an oral dose of 100 mg thalidomide and subsequent dose escalation of 400 mg thalidomide in combination with riluzole in patients with amyotrophic lateral sclerosis (ALS).

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 18 Sep 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Riluzole; Thalidomide
  • Indications Amyotrophic lateral sclerosis
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Mar 2009 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
    • 19 Jan 2007 Biomarkers information updated
    • 01 Sep 2006 New trial record.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top